The sensitivity of MM cell lines to ABT‐199 correlated most closely with their Bcl‐2/Mcl‐1 mRNA expression ratio, with the most sensitive cell lines expressing high levels of Bcl‐2 relative to Mcl‐1, a known resistance factor for Bcl‐2 inhibitors. The gene discussed is BCL2; the disease is Miyoshi myopathy.